Natália Bindi Sanchez
About Natália Bindi Sanchez
Natália Bindi Sanchez is a Patient Safety Coordinator at Bristol Myers Squibb in São Paulo, Brazil, with extensive experience in pharmacovigilance and drug safety management.
Current Title and Company
Natália Bindi Sanchez currently serves as a Patient Safety Coordinator at Bristol Myers Squibb in São Paulo, Brazil. Her role involves ensuring the safety of patients through meticulous pharmacovigilance practices and risk management.
Previous Positions
Natália Bindi Sanchez has held various positions in the pharmacovigilance field. She worked at Celgene as a Drug Safety and Risk Management Coordinator and LDSO Brazil Deputy from 2018 to 2021. Before that, she was a Senior Pharmacovigilance Analyst at Galderma for two years and a Pl Pharmacovigilance Analyst at the same company from 2013 to 2015. Her earlier roles include Junior Pharmacovigilance Analyst at Hypermarcas S/A, Pharmacovigilance Trainee at Ranbaxy, and Toxiclin Serviços Médicos. She began her career as a Trainee at the Criminalistics Institute - Center of Drug Tests.
Education and Professional Qualifications
Natália Bindi Sanchez studied at Faculdades Oswaldo Cruz, where she earned a degree in Farmácia, Ciências Farmacêuticas e Gestão Farmacêutica from 2007 to 2011. She also obtained a professional qualification in Clinical Trials from Invitare Pesquisa Clínica, studying Clinical Trials for 11 months in 2013.
Experience in CAPAs Management
Natália Bindi Sanchez has substantial experience in managing CAPAs (Corrective and Preventive Actions). She has implemented and managed CAPAs within her roles in the pharmaceutical industry, ensuring quality and compliance in safety practices.
Involvement in Crisis Management and Regulatory Meetings
Throughout her career, Natália Bindi Sanchez has participated in her company's Crisis Committees. She has engaged in meetings with national entities, public authorities, organizations, and associations to discuss and manage drug safety and risk management concerns.